Drug target discovery by magnetic nanoparticles coupled mass spectrometry
Drug target discovery is the basis of drug screening. It elucidates the cause of disease and the mechanism of drug action, which is the essential of drug innovation. Target discovery performed in biological systems is complicated as proteins are in low abundance and endogenous compounds may interfer...
Saved in:
Main Authors: | Dandan Xia (Author), Baoling Liu (Author), Xiaowei Xu (Author), Ya Ding (Author), Qiuling Zheng (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid and sensitive analysis of trace β-blockers by magnetic solid-phase extraction coupled with Fourier transform ion cyclotron resonance mass spectrometry
by: Xue Xiao, et al.
Published: (2022) -
Mass Spectrometry Technology for Protein Biomarker Discovery
by: Sermin Tetik
Published: (2016) -
Editorial: Microfluidics and mass spectrometry in drug discovery and development: from synthesis to evaluation
by: Giuseppe Caruso, et al.
Published: (2023) -
Determination of 11 minerals in children using inductively coupled plasma mass spectrometry
by: Xiaofeng Li, et al.
Published: (2021) -
Determination of Elemental Impurities in Gelatine Capsules by Inductively Coupled Plasma Mass Spectrometry
by: V. M. Shchukin, et al.
Published: (2024)